42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cytokine-Regulated GADD45G Induces Differentiation and Lineage Selection in Hematopoietic Stem Cells

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          The balance of self-renewal and differentiation in long-term repopulating hematopoietic stem cells (LT-HSC) must be strictly controlled to maintain blood homeostasis and to prevent leukemogenesis. Hematopoietic cytokines can induce differentiation in LT-HSCs; however, the molecular mechanism orchestrating this delicate balance requires further elucidation. We identified the tumor suppressor GADD45G as an instructor of LT-HSC differentiation under the control of differentiation-promoting cytokine receptor signaling. GADD45G immediately induces and accelerates differentiation in LT-HSCs and overrides the self-renewal program by specifically activating MAP3K4-mediated MAPK p38. Conversely, the absence of GADD45G enhances the self-renewal potential of LT-HSCs. Videomicroscopy-based tracking of single LT-HSCs revealed that, once GADD45G is expressed, the development of LT-HSCs into lineage-committed progeny occurred within 36 hr and uncovered a selective lineage choice with a severe reduction in megakaryocytic-erythroid cells. Here, we report an unrecognized role of GADD45G as a central molecular linker of extrinsic cytokine differentiation and lineage choice control in hematopoiesis.

          Graphical Abstract

          Highlights

          • Molecular mechanism of cytokine-mediated differentiation induction in LT-HSCs

          • Cytokine-regulated GADD45G induces and accelerates differentiation in LT-HSCs

          • The absence of GADD45G increases the self-renewal capacity in LT-HSCs

          • GADD45G-induced program selects for myelomonocytic and lymphoid lineages

          Abstract

          Rieger and colleagues report an unrecognized function of the tumor suppressor GADD45G as a molecular link of differentiation-promoting cytokine signaling and rapid differentiation induction in hematopoiesis. Cytokine-regulated GADD45G induces and accelerates hematopoietic stem cell differentiation and overrides the self-renewal program by specifically activating MAP3K4-mediated MAPK p38. Videomicroscopy-based single stem cell tracking further revealed a GADD45G-mediated selective lineage choice against megakaryocytic-erythroid fate.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells.

          Hematopoietic stem cells (HSCs) undergo self-renewing cell divisions and maintain blood production for their lifetime. Appropriate control of HSC self-renewal is crucial for the maintenance of hematopoietic homeostasis. Here we show that activation of p38 MAPK in response to increasing levels of reactive oxygen species (ROS) limits the lifespan of HSCs in vivo. In Atm(-/-) mice, elevation of ROS levels induces HSC-specific phosphorylation of p38 MAPK accompanied by a defect in the maintenance of HSC quiescence. Inhibition of p38 MAPK rescued ROS-induced defects in HSC repopulating capacity and in the maintenance of HSC quiescence, indicating that the ROS-p38 MAPK pathway contributes to exhaustion of the stem cell population. Furthermore, prolonged treatment with an antioxidant or an inhibitor of p38 MAPK extended the lifespan of HSCs from wild-type mice in serial transplantation experiments. These data show that inactivation of p38 MAPK protects HSCs against loss of self-renewal capacity. Our characterization of molecular mechanisms that limit HSC lifespan may lead to beneficial therapies for human disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Forcing cells to change lineages.

            The ability to produce stem cells by induced pluripotency (iPS reprogramming) has rekindled an interest in earlier studies showing that transcription factors can directly convert specialized cells from one lineage to another. Lineage reprogramming has become a powerful tool to study cell fate choice during differentiation, akin to inducing mutations for the discovery of gene functions. The lessons learnt provide a rubric for how cells may be manipulated for therapeutic purposes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Awakening dormant haematopoietic stem cells.

              Haematopoietic stem cells (HSCs) in mouse bone marrow are located in specialized niches as single cells. During homeostasis, signals from this environment keep some HSCs dormant, which preserves long-term self-renewal potential, while other HSCs actively self renew to maintain haematopoiesis. In response to haematopoietic stress, dormant HSCs become activated and rapidly replenish the haematopoietic system. Interestingly, three factors - granulocyte colony-stimulating factor, interferon-alpha and arsenic trioxide - have been shown to efficiently activate dormant stem cells and thereby could break their resistance to anti-proliferative chemotherapeutics. Thus, we propose that two-step strategies could target resistant leukaemic stem cells by priming tumours with activators of dormancy followed by chemotherapy or targeted therapies.
                Bookmark

                Author and article information

                Contributors
                Journal
                Stem Cell Reports
                Stem Cell Reports
                Stem Cell Reports
                Elsevier
                2213-6711
                19 June 2014
                19 June 2014
                08 July 2014
                : 3
                : 1
                : 34-43
                Affiliations
                [1 ]LOEWE Center for Cell and Gene Therapy and Department for Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
                [2 ]Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, 60596 Frankfurt am Main, Germany
                [3 ]Institute of Computational Biology, Helmholtz Zentrum Munich, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany
                [4 ]Department of Mathematics, TU Munich, Boltzmannstrasse 3, 85747 Garching, Germany
                [5 ]Laboratory of Genetics and Physiology, NIDDK, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
                [6 ]Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland
                [7 ]German Cancer Consortium (DKTK), Heidelberg, Germany
                [8 ]German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
                Author notes
                []Corresponding author m.rieger@ 123456em.uni-frankfurt.de
                Article
                S2213-6711(14)00151-9
                10.1016/j.stemcr.2014.05.010
                4110750
                25068120
                29f29507-e47a-4562-a9f5-d7ee9c765c3e
                © 2014 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

                History
                : 28 November 2013
                : 13 May 2014
                : 14 May 2014
                Categories
                Report

                Comments

                Comment on this article